Diagnostic Utility of Diffusion Tensor Imaging in Differentiating Glioblastomas from Brain Metastases

REFERENCES

1. 1.↵
   1. Giese A,
   2. Westphal M

   . Treatment of malignant glioma: a problem beyond the margins of resection. J Cancer Res Clin Oncol 2001;127:217–25

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Soffietti R,
   2. Ruda R,
   3. Mutani R

   . Management of brain metastases. J Neurol 2002;249:1357–69

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Schiff D

   . Single brain metastasis. Curr Treat Options Neurol 2001;3:89–99

   CrossRefPubMed
4. 4.↵
   1. Lu S,
   2. Ahn D,
   3. Johnson G,
   4. et al

   . Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. AJNR Am J Neuroradiol 2003;24:937–41

   Abstract/FREE Full Text
5. 5.↵
   1. Lu S,
   2. Ahn D,
   3. Johnson G,
   4. et al

   . Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration index. Radiology 2004;232:221–28

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Morita K,
   2. Matsuzawa H,
   3. Fujii Y,
   4. et al

   . Diffusion tensor analysis of peritumoral edema using lambda chart analysis indicative of the heterogeneity of the microstructure within edema. J Neurosurg 2005;102:336–41

   CrossRefPubMed
7. 7.↵
   1. Yamasaki F,
   2. Kurisu K,
   3. Satoh K,
   4. et al

   . Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology 2005;235:985–91

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Calli C,
   2. Kitis O,
   3. Yunten N,
   4. et al

   . Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 2006;58:394–403

   CrossRefPubMed
9. 9.↵
   1. Oh J,
   2. Cha S,
   3. Aiken AH,
   4. et al

   . Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema. J Magn Reson Imaging 2005;21:701–08

   CrossRefPubMed
10. 10.↵
    1. Wang W,
    2. Steward CE,
    3. Desmond PM

    . Diffusion tensor imaging in glioblastoma multiforme and brain metastases: the role of p, q, L, and fractional anisotropy. AJNR Am J Neuroradiol 2009;30:203–08

    Abstract/FREE Full Text
11. 11.↵
    1. Reiche W,
    2. Schuchardt V,
    3. Hagen T,
    4. et al

    . Differential diagnosis of intracranial ring enhancing cystic mass lesions–role of diffusion-weighted imaging (DWI) and diffusion-tensor imaging (DTI). Clin Neurol Neurosurg 2010;112:218–25

    CrossRefPubMed
12. 12.↵
    1. Wang S,
    2. Kim S,
    3. Chawla S,
    4. et al

    . Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging. Neuroimage 2009;44:653–60

    CrossRefPubMed
13. 13.↵
    1. Chen XZ,
    2. Yin XM,
    3. Ai L,
    4. et al

    . Differentiation between brain glioblastoma multiforme and solitary metastasis: qualitative and quantitative analysis based on routine MR imaging. AJNR Am J Neuroradiol 2012;33:1907–12

    Abstract/FREE Full Text
14. 14.↵
    1. Kinoshita M,
    2. Hashimoto N,
    3. Goto T,
    4. et al

    . Fractional anisotropy and tumor cell density of the tumor core show positive correlation in diffusion tensor magnetic resonance imaging of malignant brain tumors. Neuroimage 2008;43:29–35

    CrossRefPubMed
15. 15.↵
    1. Murakami R,
    2. Hirai T,
    3. Sugahara T,
    4. et al

    . Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method. Radiology 2009;251:838–45

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Stadlbauer A,
    2. Ganslandt O,
    3. Buslei R,
    4. et al

    . Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. Radiology 2006;240:803–10

    CrossRefPubMed
17. 17.↵
    1. Al-Okaili RN,
    2. Krejza J,
    3. Woo JH,
    4. et al

    . Intraaxial brain masses: MR imaging-based diagnostic strategy–initial experience. Radiology 2007;243:539–50

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Kim S,
    2. Pickup S,
    3. Hsu O,
    4. et al

    . Diffusion tensor MRI in rat models of invasive and well-demarcated brain tumors. NMR Biomed 2008;21:208–16

    CrossRefPubMed
19. 19.↵
    1. Beppu T,
    2. Inoue T,
    3. Shibata Y,
    4. et al

    . Fractional anisotropy value by diffusion tensor magnetic resonance imaging as a predictor of cell density and proliferation activity of glioblastomas. Surg Neurol 2005;63:56–61

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Hope T,
    2. Westlye LT,
    3. Bjornerud A

    . The effect of gradient sampling schemes on diffusion metrics derived from probabilistic analysis and tract-based spatial statistics. Magn Reson Imaging 2012;30:402–12

    CrossRefPubMed
21. 21.↵
    1. Jones DK

    . The effect of gradient sampling schemes on measures derived from diffusion tensor MRI: a Monte Carlo study. Magn Reson Med 2004;51:807–15

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Landman BA,
    2. Farrell JA,
    3. Jones CK,
    4. et al

    . Effects of diffusion weighting schemes on the reproducibility of DTI-derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5T. Neuroimage 2007;36:1123–38

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Wang S,
    2. Kim S,
    3. Chawla S,
    4. et al

    . Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2011;32:507–14

    Abstract/FREE Full Text
24. 24.↵
    1. Westin CF,
    2. Maier SE,
    3. Mamata H,
    4. et al

    . Processing and visualization for diffusion tensor MRI. Med Image Anal 2002;6:93–108

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Wang S,
    2. Kim S,
    3. Zhang Y,
    4. et al

    . Determination of grade and subtype of meningiomas by using histogram analysis of diffusion-tensor imaging metrics. Radiology 2012;262:584–92

    CrossRefPubMed
26. 26.↵
    1. Rutter CM

    . Bootstrap estimation of diagnostic accuracy with patient-clustered data. Acad Radiol 2000;7:413–19

    CrossRefPubMedWeb of Science
27. 27.↵
    1. DeLong ER,
    2. DeLong DM,
    3. Clarke-Pearson DL

    . Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837–45

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Toh CH,
    2. Wei KC,
    3. Ng SH,
    4. et al

    . Differentiation of tumefactive demyelinating lesions from high-grade gliomas with the use of diffusion tensor imaging. AJNR Am J Neuroradiol 2012;33:846–51

    Abstract/FREE Full Text
29. 29.↵
    1. Toh CH,
    2. Wei KC,
    3. Ng SH,
    4. et al

    . Differentiation of brain abscesses from necrotic glioblastomas and cystic metastatic brain tumors with diffusion tensor imaging. AJNR Am J Neuroradiol 2011;32:1646–51

    Abstract/FREE Full Text
30. 30.↵
    1. Zamecnik J

    . The extracellular space and matrix of gliomas. Acta Neuropathol 2005;110:435–42

    CrossRefPubMed
31. 31.↵
    1. Vargova L,
    2. Homola A,
    3. Zamecnik J,
    4. et al

    . Diffusion parameters of the extracellular space in human gliomas. Glia 2003;42:77–88

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Pope WB,
    2. Mirsadraei L,
    3. Lai A,
    4. et al

    . Differential gene expression in glioblastoma defined by ADC histogram analysis: relationship to extracellular matrix molecules and survival. AJNR Am J Neuroradiol 2012;33:1059–64

    Abstract/FREE Full Text
33. 33.↵
    1. Tropine A,
    2. Dellani PD,
    3. Glaser M,
    4. et al

    . Differentiation of fibroblastic meningiomas from other benign subtypes using diffusion tensor imaging. J Magn Reson Imaging 2007;25:703–08

    CrossRefPubMed
34. 34.↵
    1. Stylianopoulos T,
    2. Diop-Frimpong B,
    3. Munn LL,
    4. et al

    . Diffusion anisotropy in collagen gels and tumors: the effect of fiber network orientation. Biophys J 2010;99:3119–28

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Preusser M,
    2. Capper D,
    3. Ilhan-Mutlu A,
    4. et al

    . Brain metastases: pathobiology and emerging targeted therapies. Acta Neuropathol 2012;123:205–22

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Varga I,
    2. Hutoczki G,
    3. Petras M,
    4. et al

    . Expression of invasion-related extracellular matrix molecules in human glioblastoma versus intracerebral lung adenocarcinoma metastasis. Cent Eur Neurosurg 2010;71:173–80

    CrossRefPubMed